Psoriasis and uveitis: links and risks

QR Code

Psoriasis and uveitis: links and risks

Christina Fotiadou, Elizabeth LazaridouSecond Department of Dermatology-Venereology, Aristotle University Medical School, Thessaloniki, GreeceCorrespondence: Christina FotiadouSecond Department of Dermatology-Venereology, Aristotle University Medical School, 1 Chrysochoou Street 1221, Larisa, Greece...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Fotiadou C, Lazaridou E
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2019
Sujets:	Psoriasis Uveitis Pathogenetic Link Dermatology RL1-803
Accès en ligne:	https://doaj.org/article/f0f79b5f53d64d448cd9053b13322fcc
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Type 2 diabetes and psoriasis: links and risks
par: Holm JG, et autres
Publié: (2019)

A narrative review of psoriasis and multiple sclerosis: links and risks
par: Silfvast-Kaiser AS, et autres
Publié: (2019)

Dermoscopic hemorrhagic dots: an early predictor of response of psoriasis to biologic agents
par: Aimilios Lallas, et autres
Publié: (2016)

Psoriasis and sexual dysfunction: links, risks, and management challenges
par: Duarte GV, et autres
Publié: (2018)

Common Fundamentals of Psoriasis and Depression
par: Stefanie Hölsken, et autres
Publié: (2021)

Pustular psoriasis: pathophysiology and current treatment perspectives
par: Benjegerdes KE, et autres
Publié: (2016)

Psoriasis and smoking: links and risks
par: Naldi L
Publié: (2016)

Updates on the Treatment of Erythrodermic Psoriasis
par: Lo Y, et autres
Publié: (2021)

Psoriasis and alcohol
par: Svanström C, et autres
Publié: (2019)

Targeting IL-23 in psoriasis: current perspectives
par: Fotiadou C, et autres
Publié: (2018)

Psoriasis and inflammatory bowel disease: links and risks
par: Vlachos C, et autres
Publié: (2016)

Psoriasis: Targets and Therapy
Publié: (2012)

Links and risks associated with psoriasis and metabolic syndrome
par: Liakou AI, et autres
Publié: (2015)

Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
par: Hampton P, et autres
Publié: (2021)

Management of scalp psoriasis: current perspectives
par: Blakely K, et autres
Publié: (2016)

Spotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date
par: Machado Á, et autres
Publié: (2018)

Risankizumab for Plaque and Guttate Psoriasis in a Patient With IgA-Related Glomerulonephritis
par: Annunziata Dattola, et autres
Publié: (2021)

Current knowledge on psoriasis and autoimmune diseases
par: Ayala-Fontánez N, et autres
Publié: (2016)

Off-Label Treatments for Pediatric Psoriasis: Lessons for the Clinic
par: Haulrig MB, et autres
Publié: (2021)

Psoriasis and Cardiometabolic Diseases: The Impact of Inflammation on Vascular Health
par: Teklu M, et autres
Publié: (2021)

Serum TSLP is a potential biomarker of psoriasis vulgaris activity
par: El-Ghareeb MI, et autres
Publié: (2019)

Assessment and monitoring of biologic drug adverse events in patients with psoriasis
par: Hanley T, et autres
Publié: (2016)

Diagnosis and screening of patients with generalized pustular psoriasis
par: Ly K, et autres
Publié: (2019)

Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study
par: Riccardo G. Borroni, et autres
Publié: (2021)

An Atypical Case of Pustular Psoriasis Presenting With Severe Subungual Abscesses Involving All Fingers
par: A. Tulin Mansur
Publié: (2019)

Single-center, noninterventional clinical trial to assess the safety, efficacy, and tolerability of a dimeticone-based medical device in facilitating the removal of scales after topical application in patients with psoriasis corporis or psoriasis capitis
par: Hengge UR, et autres
Publié: (2017)

Erythrodermic psoriasis: pathophysiology and current treatment perspectives
par: Singh RK, et autres
Publié: (2016)

Prevalence of Metabolic Syndrome and Its Parameters and Their Correlations With Psoriasis Duration, Severity, and Sleep Quality In Psoriasis Patients: A Cross-Sectional Study
par: Betul Tas, et autres
Publié: (2021)

The new external drug for the treatment of psoriasis based on inhibition of serine proteases
par: Alexander S. Zhukov, et autres
Publié: (2021)

Tacrolimus for the management of psoriasis: clinical utility and place in therapy
par: Malecic N, et autres
Publié: (2016)

Clinical evidence of therapy for genital psoriasis by biologic agents
par: Evgeny V. Sokolovskiy, et autres
Publié: (2021)

Phosphodiesterase-4 Inhibition in Psoriasis
par: Milakovic M, et autres
Publié: (2021)

The Use of Apremilast in Psoriasis: An Indian Perspective on Real-World Scenarios
par: Rajagopalan M, et autres
Publié: (2021)

Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives
par: Campanati A, et autres
Publié: (2017)

Psoriasis In Patients With Active Lung Cancer: Is Apremilast a Safe Option?
par: Zoe Apalla, et autres
Publié: (2019)

Integrating lifestyle-focused approaches into psoriasis care: improving patient outcomes?
par: Landriscina A, et autres
Publié: (2016)

Dermoscopy Differentiates Guttate Psoriasis From a Mimicker—Pityriasis Rosea
par: Meena Makhecha, et autres
Publié: (2021)

Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
par: Aline Lissa Okita, et autres
Publié: (2020)

Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids
par: Svendsen MT, et autres
Publié: (2016)

Monitoring treatment response in psoriasis: current perspectives on the clinical utility of reflectance confocal microscopy
par: Agozzino M, et autres
Publié: (2017)